Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | CTSS | P25774 | 3/20 | 0.38 |
| ▸ | CTSK | P43235 | 3/20 | 0.38 |
| ▸ | CA2 | P00918 | 3/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | SYK | P43405 | 1/20 | 0.34 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.32 |
| ▸ | NOS1 | P29475 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | NOS3 | P29474 | 1/20 | 0.32 |
| ▸ | NOS2 | P35228 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28710632 | 1.00 | KMT2A (0.39) | KMT2AMEN1GAACTSSCTSK | |
| Methylamine SCHEMBL28534491 | 0.96 | KMT2A (0.37) | KMT2AMEN1GAACTSSCTSK | |
| SCHEMBL1344807 | 0.91 | CTSK (0.36) | KMT2AMEN1GAACTSSCTSK | |
| SCHEMBL28173071 | 0.84 | CTSS (0.33) | KMT2AMEN1GAACTSSCTSK | |
| SCHEMBL31604 | 0.83 | CHRM1 (0.43) | KMT2AMEN1GAACTSSCTSK | |
| SCHEMBL2439297 | 0.83 | HTT (0.40) | KMT2AMEN1GAALMNACYP1A2 | |
| SCHEMBL19206295 | 0.83 | KMT2A (0.34) | KMT2AMEN1GAACTSSCTSK | |
| SCHEMBL4477961 | 0.83 | CA1 (0.42) | KMT2AMEN1GAACTSSCTSK | |
| SCHEMBL27969605 | 0.83 | CTSK (0.33) | KMT2AMEN1GAACTSSCTSK | |
| SCHEMBL4864421 | 0.83 | NOS1 (0.33) | KMT2AMEN1GAACTSSCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115876926-A | Method for detecting BOC butyric acid in water and algae culture medium by using HPLC-MS/MS | 贵州健安德科技有限公司 | 2023-03-31 | — | — | CN | claimed |
| CN-113273075-A | Electrostatic machine system and method of operation | C-莫蒂夫技术公司 | 2021-08-17 | — | — | CN | claimed |
| CN-115876926-B | Method for detecting BOC butyric acid in water and algae culture medium by utilizing HPLC-MS/MS | 贵州健安德科技有限公司 | 2025-09-23 | — | — | CN | disclosed |
| CN-115876926-B | Method for detecting BOC butyric acid in water and algae culture medium by utilizing HPLC-MS/MS | 贵州健安德科技有限公司 | 2025-09-23 | — | — | CN | disclosed |
| WO-2025098432-A1 | mIDH1/NAMPT DUAL-TARGET INHIBITOR AND USE THEREOF | 中国药科大学 | 2025-05-15 | — | — | WO | disclosed |
| CN-116217440-B | Preparation method of sitagliptin key intermediate | 浙江永太手心医药科技有限公司 | 2024-07-02 | — | — | CN | disclosed |
| CN-118063351-B | Green synthesis of chiral beta amino acids using biological enzymes and immobilized aminotransferase used | 北京元延医药科技股份有限公司 | 2024-06-28 | — | — | CN | disclosed |
| CN-118063351-A | Green synthesis of chiral beta amino acids using biological enzymes and immobilized aminotransferase used | 北京元延医药科技股份有限公司 | 2024-05-24 | — | — | CN | disclosed |
| CN-114940648-B | Method for preparing malonic acid mono-tert-butyl ester by catalysis of strong acid resin | 常州夏青科技有限公司 | 2023-11-21 | — | — | CN | disclosed |
| CN-111170991-B | Antiproliferative compounds and methods of synthesis thereof | 细胞基因公司 | 2023-10-31 | — | — | CN | disclosed |
| EP-3694503-B1 | NOVEL SUBSTITUTED CYCLOBUTYLPYRIDINE AND CYCLOBUTYLPYRIMIDINE COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE (IDO) INHIBITORS | MERCK SHARP & DOHME LLC (US) | 2023-08-02 | — | — | EP | disclosed |
| US-20040198736-A1 | Non-nucleoside reverse transcriptase inhibitors | ROCHE PALO ALTO LLC | 2004-10-07 | — | — | US | disclosed |
| WO-2004085406-A1 | BENZYL-PYRIDAZINONS AS REVERSE TRANSCRIPTASE INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2004-10-07 | — | — | WO | disclosed |
| US-20030225113-A1 | Bicyclic heteroaromatic compounds | MERCK SHARP & DOHME B.V. (NL) | 2003-12-04 | — | — | US | disclosed |
| EP-1322651-A1 | BICYCLIC HETEROAROMATIC COMPOUNDS | Akzo Nobel N.V. (NL) | 2003-07-02 | — | — | EP | disclosed |
| CN-1423638-A | Oxazolyl hydroxamic acids as procollagen C-protease inhibitors | PFIZER LTD (US) | 2003-06-11 | — | — | CN | disclosed |
| WO-2002024703-A1 | BICYCLIC HETEROAROMATIC COMPOUNDS | AKZO NOBEL N.V. (NL) | 2002-03-28 | — | — | WO | disclosed |
| CN-1014515-B | Process for preparing nonaromatic fluoroallylamine as MAO inhibitor | MERRELL DOW PHARMA (US) | 1991-10-30 | — | — | CN | disclosed |
| CN-86108051-A | NONAROMATIC FLUOROALLYLAMINE MAO INHIBITORS | — | 1987-08-19 | — | — | CN | disclosed |
| US-3932121-A | Process for the dyeing of modified polyester fibers | HODOGAYA KAGAKU KOGYO KABUSHIKI KAISHA (JA) | 1976-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030225113-A1 | Bicyclic heteroaromatic compounds | NR5A1, CYP19A1, FSHR | KMT2A 1849/4885MEN1 3631/4885GAA 4343/4885 |
| US-20040198736-A1 | Non-nucleoside reverse transcriptase inhibitors | POLR1A, POLR2A, POLR2E | KMT2A 2836/4885MEN1 4616/4885GAA 602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.